The fast Padé transform in magnetic resonance spectroscopy for potential improvements in early cancer diagnostics

The convergence rates of the fast Padé transform (FPT) and the fast Fourier transform (FFT) are compared. These two estimators are used to process a time-signal encoded at 4 T by means of one-dimensional magnetic resonance spectroscopy (MRS) for healthy human brain. It is found systematically that at any level of truncation of the full signal length, the clinically relevant resonances that determine concentrations of metabolites in the investigated tissue are significantly better resolved in the FPT than in the FFT. In particular, the FPT has a better resolution than the FFT for the same signal length. Moreover, the FPT can achieve the same resolution as the FFT by using twice shorter signals. Implications of these findings for two-dimensional magnetic resonance spectroscopy as well as for two- and three-dimensional magnetic resonance spectroscopic imaging are highlighted. Self-contained cross-validation of all the results from the FPT is secured by using two conceptually different, equivalent algorithms (inside and outside the unit-circle), that are both valid in the entire complex frequency plane. The difference between the results from these two variants of the FPT is indistinguishable from the background noise. This constitutes robust error analysis of proven validity. The FPT shows promise in applications of MRS for early cancer detection.

[1]  K. Belkic.  Magnetic resonance spectroscopic imaging in breast cancer detection: possibilities beyond the conventional theoretical framework for data analysis , 2004 .

[2]  Franklyn A Howe,et al.  1H MR spectroscopy of brain tumours and masses , 2003, NMR in biomedicine.

[3]  Devad B√©lkic.  Quantum-Mechanical Signal Processing and Spectral Analysis , 2004 .

[4]  Howard S. Taylor,et al.  Decimation and harmonic inversion of periodic orbit signals , 1999, chao-dyn/9912031.

[5]  T. Mikkelsen,et al.  Correlation between Magnetic Resonance Spectroscopy Imaging and Image-guided Biopsies: Semiquantitative and Qualitative Histopathological Analyses of Patients with Untreated Glioma , 2001, Neurosurgery.

[6]  Brian D. Ross,et al.  Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases , 1999 .

[7]  F. Howe,et al.  Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS , 2003, Magnetic resonance in medicine.

[8]  R. Lenkinski,et al.  Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. , 2002, Journal of the National Cancer Institute.

[9]  M D Schnall,et al.  MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. , 2001, Radiology.

[10]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[11]  D. Belkić.  Fast Padé transform for magnetic resonance imaging and computerized tomography , 2001 .

[12]  K Ugurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at 7 T , 2001, Magnetic resonance in medicine.

[13]  Current dilemmas and future perspectives for breast cancer screening with a focus on optimization of magnetic resonance spectroscopic imaging by advances in signal processing. , 2004, The Israel Medical Association journal : IMAJ.

[14]  S Mierisová,et al.  MR spectroscopy quantitation: a review of frequency domain methods , 2001, NMR in biomedicine.

[15]  B. Sitter,et al.  Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. , 1999, Anticancer research.

[16]  J Kurhanewicz,et al.  Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.

[17]  D. Belkić.  Strikingly stable convergence of the Fast Padé Transform (FPT) for high-resolution parametric and non-parametric signal processing of Lorentzian and non-Lorentzian spectra , 2004 .

[18]  Gi-Hwan Choi,et al.  (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. , 2003, Magnetic resonance imaging.

[19]  Semiclassical quantization by Padé approximant to periodic orbit sums , 1999, chao-dyn/9909008.

[20]  R. Somorjai,et al.  Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis , 1997, Magnetic resonance in medicine.

[21]  Joseph V. Hajnal,et al.  Edge detection at low resolution using Padé approximants. , 2004 .

[22]  M. Deschamps,et al.  Nuclear magnetic resonance study of xenon-131 interacting with surfaces: Effective Liouvillian and spectral analysis , 2000 .

[23]  A Heerschap,et al.  Common processing of in vivo MR spectra , 2001, NMR in biomedicine.

[24]  S. Shibata,et al.  Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain , 2001, Neuroradiology.

[25]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[26]  S. Confort-Gouny,et al.  Optimization of residual water signal removal by HLSVD on simulated short echo time proton MR spectra of the human brain. , 2001, Journal of magnetic resonance.

[27]  P. Bottomley,et al.  The trouble with spectroscopy papers , 1992, Journal of magnetic resonance imaging : JMRI.

[28]  Marco Zaider,et al.  Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. , 2002, International journal of radiation oncology, biology, physics.

[29]  S. Nelson.  Multivoxel magnetic resonance spectroscopy of brain tumors. , 2003, Molecular cancer therapeutics.

[30]  Luigi Landini,et al.  A fast and accurate simulator for the design of birdcage coils in MRI , 2002, Magnetic Resonance Materials in Physics, Biology and Medicine.

[31]  I. Smith,et al.  Diagnosis of cancer in humans by 1H NMR of tissue biopsies , 1998 .

[32]  Howard S. Taylor,et al.  Decimated Signal Diagonalization for Fourier Transform Spectroscopy , 2000 .

[33]  R Gruetter,et al.  Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. , 1999, Journal of magnetic resonance.

[34]  Dzevad Belkic,et al.  Spectroscopic imaging through magnetic resonance for brain tumour diagnostics: Recent achievements, dilemmas and potential solutions via advances in signal processing , 2004, J. Comput. Methods Sci. Eng..

[35]  F. Howe,et al.  Magnetic Resonance Spectroscopy of cancer-practicalities of multi-centre trials and early results in non-Hodgkin's lymphoma. , 2002, European journal of cancer.

[36]  U. Engelke,et al.  High‐resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid , 2000, NMR in biomedicine.

[37]  Howard S. Taylor,et al.  Three novel high-resolution nonlinear methods for fast signal processing , 2000 .

[38]  A. Heerschap,et al.  1H‐magnetic resonance spectroscopy , 1998, Cancer.

[39]  Geoffrey D Clarke,et al.  Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9. , 2002, Medical physics.

[40]  Dževad Belkić,et al.  Decimated signal diagonalization for obtaining the complete eigenspectra of large matrices , 1999 .

[41]  J. García-Segura,et al.  In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology. , 1999, Magnetic resonance imaging.

[42]  J Kurhanewicz,et al.  Magnetic resonance imaging and spectroscopic imaging of prostate cancer. , 2003, Cancer investigation.